Market Research Blog

A recently published research intelligence on the global antibiotic susceptibility testing market by Future Market Insights tracks the top five influencers pushing demand and revenue growth of the market at a global level.

• Infectious diseases, prevailing at a high pace
• Increasing rate and tenure of hospitalization
• Growing significance of early diagnostics
• Soaring research interests in microbial susceptibility testing
• Improving funding scenario for research, driven by governments & private bodies
• Antibiotic Susceptibility Testing Market is expected to reach a valuation of US$ 4.05 Bn by 2028, expanding at a CAGR of 5.2%

Growing use of antibiotics in treating even the most common health conditions remains a strong factor boosting demand for antibiotic susceptibility testing (AST).

Increasing government funds for microbial and antibiotic susceptibility testing research and consistently improving outcome of PPPs in terms of enhanced screening and evaluation of antibiotics are playing a pivotal role in strengthening the performance of antibiotic susceptibility testing market.

CDC’s ‘AMR Challenge’ involving bioMérieux is a recently announced as objective to accelerate research efforts in the field of microbial resistance.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-8574

Research in Screening of High Pathogen Concentration Samples to Propel Demand for AST

The process of spotting a specific set of genes responsible for antibiotic resistance is highly complicated when it comes to handling the complexities associated with samples that have high concentration of pathogens.

Some of the highly desirable antibiotic susceptibility testing systems that allow direct-from-sample pathogen identification through high pathogen concentration samples, are thus likely to gain high traction in coming years.

Growing research efforts in the recognition of the presence of a specific set of antibiotic resistant genes can direct efforts for identification and selection of narrow-spectrum antibiotics, which remains among the most prominent factors pushing installed base of such antibiotic susceptibility testing equipment.

A few recent launches in this segment include Genmark Diagnostics’ ePLEX Blood Culture ID Panel, Biomerieux’s BioFire FilmArray, and Luminex Corp.’s Verigene Bloodstream Infection Panel.

The report also sheds light on the increasing role of Ecommerce in the market by boosting the availability of antibiotic susceptibility testing systems. Offering improved access to susceptibility testing devices by industry’s leading brands, online retail operators have been attracting prominent vendors in the global antibiotic susceptibility testing market.

A number of vendors dealing in antibiotic susceptibility testing equipment are opting for devices that are available online owing to the significantly reduced costs and additional discounts on price.

Entry of Technologically Advanced AST Systems to Favor Market Growth

As indicated by research, the sales of antibiotic susceptibility testing equipment will witness healthy growth owing to increasing demand for specific susceptibility testing systems to define the scope of targeted therapy.

Targeting key pathogens is imperative to design a highly specific plan of treatment for a particular patient, and antibiotic susceptibility testing systems efficiently allow researchers to achieve it within a significantly short timeline.

With FDA approving a considerable number of antibiotic and microbial susceptibility testing equipment, especially in the recent past, FMI forecasts an impressive installed base for antibiotic susceptibility testing systems in coming years.

Advanced technology enabled antibiotic susceptibility testing equipment allows early diagnosis that in turn improves chances of developing targeted therapy earlier. One such recent advancement enjoying visibly growing traction in market includes oCelloScope.

This antibiotic susceptibility testing equipment by BioSense Solutions is an optical susceptibility screening system with the capability to deliver real-time, time-lapse imaging of multiple microbial combinations, simultaneously.

Recently, Thermo Fisher Scientific, Inc. and Becton, Dickinson and Company received FDA approvals for their new launches in antibiotic susceptibility testing space. Moreover, FDA passed an approval to a susceptibility testing device by bioMérieux that has an expanded capability to identify a particular pathogen.

Browse Full Report:

https://www.futuremarketinsights.com/reports/antibiotic-susceptibility-testing-market

Market segmentation

Antibiotic Susceptibility Testing Market by Product:

• Instruments
  • Automated Broth Microdilution Systems
  • Manual Broth Microdilution Systems
  • Semi-automated Broth Microdilution Systems
• Software & Services
  • Image & Analysis Software
  • Installation Services
• Kits & Reagents

Antibiotic Susceptibility Testing Market by Application:

• Sepsis
• Respiratory Infections
• Gastrointestinal Infections
• Meningitis & Encephalitis
• Endocarditis
• Others

Antibiotic Susceptibility Testing Market by End User:

• Diagnostic Laboratories
• Hospitals
• Research Laboratories

Antibiotic Susceptibility Testing Market by Region:

• North America Antibiotic Susceptibility Testing Market
• Latin America Antibiotic Susceptibility Testing Market
• Europe Antibiotic Susceptibility Testing Market
• East Asia Antibiotic Susceptibility Testing Market
• South Asia & Pacific Antibiotic Susceptibility Testing Market
• Middle East & Africa (MEA) Antibiotic Susceptibility Testing Market

Table of Content

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3. Global Antibiotic Susceptibility Testing Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. Global Economic Outlook

4.1. Global Gross Domestic Product by Region & Country, 2013 – 2021

4.2. Healthcare Sector Outlook by Region & Country, 2013 – 2021

5. Key Inclusions

5.1. Development Roadmap for Antibiotic Susceptibility Testing Systems

5.2. Technology Assessment

Continued…!

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-8574

Have a Look at More Valuable Insights of Healthcare

Cystatin C Testing Market Size was valued at around US$ 194.3 Mn at the end of 2021. The market is projected to register a 7.5% CAGR and top a valuation of US$ 400.4 Mn by 2032

Topical Antibiotic Pharmaceuticals Market Share covering sales outlook, demand forecast & up-to-date key trends

Veterinary Antibiotics Market Demand is worth US$ 10,904.3 million in 2022. The veterinary antibiotics market is expected to expand at a sluggish CAGR of 5.8%, and reach US$ 20,277.5 million by 2032

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

[250 Pages Report] As per a latest industry analysis by Future Market Insights, the global interferons market was valued at around US$ 9.1 Bn in 2021 and is anticipated to exhibit a CAGR of 3.9% over the forecast period (2022-2032).

Attribute	Key Statistics
Global Interferons Market Estimated Size (2021E)	US$ 9.1 Bn
Projected Market Valuation (2032F)	US$ 13.8 Bn
Value-based CAGR (2022-2032)	3.9%
Collective Value Share: Top 5 Countries (2021E)	58.2%

A group of proteins produced by white blood cells, fibroblasts, and T-cells in response to viral infections, bacteria, tumor cells, and other pathogens are known as interferons. These glycoproteins, also known as cytokines, are frequently referred to as the first line of defense against pathogens.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15158

Interferons have proved to be a cutting-edge and successful treatment option for illnesses such as cancer, hepatitis, and multiple sclerosis. In November 2021, for instance, the FDA approved BESREMi for the treatment of adults living with polycythemia vera, which is a recent advancement in the interferons industry.

Polycythemia vera is a group of rare, chronic, and life-threatening blood cancers caused by a mutation in bone marrow stem cells, which further leads to an abundance of blood cells. When this happens, a person is at high risk of significant health problems such as blood clots, strokes, and heart attacks.

One of the other factors driving the global interferons market is rising focus of key players on the development of innovative interferon-beta medications. Key players are also focusing on expanding their presence with the help of promotions, improved distribution networks, and enhanced customer services related to their products for the betterment of the brand and products.

For instance, in March 2020, Bayer and Curadev signed a research collaboration and license agreement to develop a novel stimulator of interferon genes (STING) antagonists across indications. It is known to help activate the innate immune system in auto-inflammatory diseases. Such breakthroughs in the global market are projected to bode well for the interferons industry in the upcoming decade.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15158

Key Takeaways: Interferons Market

• By product, interferon beta is the leading segment with a market share of around 2% in 2021.
• In terms of indication, the multiple sclerosis segment dominates the interferons market and held a share of around 0% in 2021.
• Based on end user, hospital pharmacies are expected to lead the interferons market and it generated a share of nearly 5% in 2021.
• North America is considered to be the leading region in the interferons market with a share of about 2% in 2021.

“Growing number of therapeutic interferon approvals and their surging commercial applications in several disease indications are expected to propel the global interferons market,” says an analyst of Future Market Insights.

Competitive Landscape: Interferons Market

Leading manufacturers such as Pfizer, Merck & Co., Zydus Cadila, and Novartis AG are focusing on collaborations and acquisitions to enhance their presence in the market and compete with their rivals during the forecast period. Below are some of the latest industry developments by key market participants:

• In March 2022, Pfizer completed the acquisition of Arena Pharmaceuticals to expand its inflammation and immunology therapeutics segment.
• In January 2022, Pfizer and Beam Therapeutics announced an exclusive collaboration to explore innovative In Vivo base editing projects for three targets in rare genetic illnesses of the liver, muscle, and central nervous system.
• In January 2022, Merck & Co. completed the acquisition of Exelead and aims to invest more than € 500 million in technical scale-up. Merck’s Life Science business segment will be able to provide comprehensive end-to-end contract development and manufacturing organization (CDMO) services across the mRNA value chain as a result of the acquisition.

For in-depth insights, Download a PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15158

More Valuable Insights on Interferons Market:

Future Market Insights brings a comprehensive research report on projected revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032. The global interferons market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the interferons market segments based on product (interferon gamma, interferon beta, and interferon alpha), indication (multiple sclerosis, polycythemia vera, hepatitis C, melanoma, chronic granulomatous disease (CGD), and other indications), and end user (hospital pharmacies, retail pharmacies, specialty clinics, and online pharmacies) across seven major regions.

Interferons Market Outlook by Category

By Product:

• Interferon Gamma
• Interferon Beta
• Interferon Alpha

By Indication:

• Multiple Sclerosis
• Polycythemia Vera
• Hepatitis C
• Melanoma
• Chronic Granulomatous Disease (CGD)
• Other Indications

By End User:

• Hospital Pharmacies
• Retail Pharmacies
• Specialty Clinics
• Online Pharmacies

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[190 Pages] As per Future Market Insights (FMI), driven by rising cases of cancer and cardiovascular diseases, radiopharmaceutical market registered steady year-on-year growth at 4.90% CAGR in 2021.

Increasing development of radioisotopes to curb the cases of cancer have propelled the market demand, topping a valuation of US$ 6,107.2 Mn in 2021. Rising cases of prostate and breast cancer, especially in developed countries including the U.S., the U.K., and Germany, have increased the application of radiopharmaceuticals.

Increasing preference of non-invasive medical therapies and production of radioisotopes for the treatment is another factor that will stabilize the growth of radiopharmaceuticals market. Based on this, FMI projects the market is poised to expand at over 4.66% CAGR during the forecast period of 2021 and 2031.

Government initiatives and research activities undertaken to develop advanced radioisotopes for the treatment of cancer and to develop novel therapeutics will boost the demand. Also, introduction of novel technologies such as Positron Emission Technology and others in nuclear imaging systems will bolster growth.

However, due to the global shutdown witnessed in the FQ-20 in response to the COVID-19 outbreak, growth declined considerably. Suspended production of radioisotopes and disruption in the research activities delayed the deployment of projects in the healthcare sector.

Although, with increasing development activities and increasing commercialization of radiopharmaceuticals by industry giants have picked up the pace for the growth of market. Alongside this, increasing cases of cancer will accelerate the development of nuclear medicines in the field of radiopharmaceuticals.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1992

Prominent Players:

Siemens AG

Positron Corporation

Novartis (Advanced Accelerator Applications)

Curium

GE Healthcare

Lantheus Holdings Inc.

Sotera Health LLC

Bayer AG

Eckert & Ziegler

Key Takeaways from FMI’s Radiopharmaceuticals Market Study

In terms of application, oncology will contribute over 50% of global market share owing to the rising prevalence of cancer across the globe.

Cyclotrons are expected to be the primary source of radiopharmaceuticals, accounting for maximum market share

Based on radioisotope type, technetium-99 will remain highly preferred radioisotope in the global radiopharmaceutical market

The U.S. will retain its global dominance backed by the high cancer and cardiovascular cases rising in the country

India will emerge as lucrative market owing to the favorable government initiatives promoting the radiopharmaceuticals market

Germany and the U.K. are spearheading the growth of Europe market, which is projected to grow at over 4.9% CAGR

“Increasing research and development initiatives aimed at the production of advanced radioisotopes and novel technologies will improve growth prospects for the leading players in the radiopharmaceuticals market,” says the FMI analyst.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1992

Competitive Landscape

Leading radiopharmaceuticals market players are focusing on expanding their customer base through strategic mergers and acquisition. Increasing research and development activities to develop advanced radioisotopes for the cancer treatment is another core strategy adopted by leading players.

Top 5 players including Siemens AG, GE Healthcare, Curium, Lantheus Holdings Inc., and Eckert & Ziegler are dominating the global radiopharmaceuticals market, contributing over 90% of revenue share.

In March 2021, Novartis announced the commercialization and obtained the rights to develop the therapeutic applications of Fibroblast Activation Protein (FAP) targeting agents including FAPI-46 and FAPI-74, through an assignment agreement with iTheranostics, Inc., an affiliate of SOFIE Biosciences, Inc.

Along with it the company announced the production and commercialization of new nuclear medicine, 18F sodium fluoride radiopharmaceutical in France.

In November 2020, Blue Earth Diagnostics, a leading molecular imaging diagnostic company, unveiled that their manufacturing company, Nucleis has manufactured and shipped their first doses of rhPSMA-7.3 (18F), an investigational Prostate-Specific Membrane Antigen (PSMA)-targeted radiohybrid PET imaging agent, for patients with prostate cancer.

Another industry giant, Jubilant Pharma Limited Company, in 2019, announced the integration of its radiopharmaceutical drug development and manufacturing business with its radio-pharmacy business into a global radiopharmaceutical brand, Jubilant Radiopharma.

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/1992

Radiopharmaceuticals Market by Category

By Radioisotope Type:

Technetium-99

Fluorine-18

Iodine-131

Leutetium-177

Yttrium-90

Gallium-68

Gallium-67

Rubidium-82

Iodine-123

Iodine-125

Indium-111

Others

By Application:

Oncology

Cardiology

Gastroenterology

Neuroendocrinology

Neurology

Nephrology

Others

By Source:

Cyclotrons

Nuclear Reactors

By End-User:

Hospitals

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Cancer Research Institute

By Region:

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific excluding Japan

Japan

Middle East & Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[240 Pages Report] A recent market study published by Future Market Insights (FMI) on the magnetic resonance imaging (MRI) contrast agents market offers global industry analysis for 2014-2018 and opportunity assessment for 2019-2029. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the magnetic resonance imaging contrast agents market, growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the magnetic resonance imaging contrast agents market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the MRI contrast agents market in the coming years. The report provides detailed information about the current and future growth prospects of the magnetic resonance imaging contrast agents market in the most comprehensive way for better understanding of readers.

Data Points	Market Insights
Market Value 2022	U.S. $ 910.9 Mn
Market Value 2029	U.S. $ 1.23 Bn
CAGR 2022-2029	4.4%
Share of top 5 countries	60.8%

Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11023

Magnetic Resonance Imaging (MRI) Contrast Agents Market : Segmentation

FMI’s study on the magnetic resonance imaging contrast agents market offers information divided into three important segments— product type, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

By Product

• Paramagnetic Contrast Agents
  • Extracellular Fluid (ECF) Agents
  • Blood Pool Contrast Agents (BPCAs)
  • Organ-specific Agents
• Superparamagnetic Contrast Agent

End User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-11023

Chapter 1 – Executive Summary

The report commences with the executive summary of the MRI contrast agents market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the magnetic resonance imaging contrast agents market, as well as the key trends impacting the market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy, definition of the magnetic resonance imaging contrast agents market, and the key inclusions and exclusions in this chapter, which help readers understand basic information about MRI contrast agents.

Chapter 3 – Key Market Trends

This section highlights the key trends impacting the magnetic resonance imaging contrast agents market, which will help readers understand the current trends and their impact on market growth.

Chapter 4 – Key Success Factors

In this chapter, the reader can get information about the parent market of MRI contrast agents market. Novel use cases, product adoption by region, product USPs, number of scans by country, and how combination imaging modalities will enhance medical imaging.

Chapter 5 – Global Magnetic Resonance Imaging Contrast Agents Market Volume (In Liters) Analysis 2014-2018 and Forecast, 2019-2029

This section explains the current and future market volume (In Liters) projections and the growth trend. Readers can also get knowledge the current installed base of MRI Units, by region/ country and historical market volume (In Liters) of global magnetic resonance imaging (MRI) contrast agents market.

Chapter 6 – Global Magnetic Resonance Imaging Contrast Agents Market – Pricing Analysis

The report covers the pricing analysis of the market on the basis of region and other attributes in this chapter. It will help the reader find comparative analysis of product pricing across different regions of the globe.

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/11023

Chapter 7 – Global Magnetic Resonance Imaging Contrast Agents Market Value (US$) Analysis 2014-2018 and Forecast, 2019-2029

This section explains the global market value analysis and forecast for the MRI contrast agents market during the forecast period of 2019-2029. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[250 Pages Report] The rising prevalence of acute respiratory failures (ARF) due to the COVID-19 outbreak, risk of community infection, increasing demand for high flow nasal cannula, and advancements in high Flow Oxygen Therapy Devices are some key factors contributing to the growth of the high flow oxygen therapy devices market.

According to a recent study by Future Market Insights (FMI), these factors have proven crucial at enabling growth in the high flow oxygen therapy devices market. Sales of high flow oxygen therapy devices are expected to top US$ 1.7 Bn in 2021, at a CAGR of -6.4% during 2021-2025 and CAGR of 1.4% during the forecast period (2025-2031).

Public health issues worldwide, including Acute Respiratory Failure (ARF), pneumonia, asthma, and interstitial lung disease, pose a significant socioeconomic burden on individuals and societies.

Presently, COVID-19 is the primary risk factor for ARF. COVID-19 symptoms such as low blood-oxygen level and pneumonia in patients increase the risk of ARFs. Because of the growing ageing population and increased exposure to risk factors, ARF and pneumonia are becoming more prominent problems across the world, which is fuelling the demand for high flow oxygen therapy devices.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13794

The World Health Organization (WHO) Child Health Epidemiology Reference Group estimates that the pneumonia resulted 105.7 million new cases in 2017; of these 13% were severe and needed immediate hospitalization.

Consistent rise in incidence of pneumonia will fuel the demand for high floe oxygen therapy devices through the forecast period. Indoor air pollution was a major risk factor that was estimated to have led to 29% of pneumonia deaths in 2017.

Outdoor air pollution was responsible for another 18% of all deaths. In addition, an increase of 81.1% in the number of pneumoconiosis cases were observed for both sexes from 1990 to 2017 worldwide. Thus, the growing burden of respiratory diseases along with the outbreak of COVID-19 across the world is expected to drive the high flow oxygen therapy devices market.

Key Takeaways from High Flow Oxygen Therapy Devices Market Study

• Demand for heated humidifiers is expected to grow at -6.6% CAGR during 2021-2025 and 1.3% CAGR through 2025-2031, owing to the occurrence of the COVID-19 pandemic.
• The acute respiratory failure segment accounted for a higher share of 90% among applications. This can be due to the rising COVID-19 cases that lead to acute respiratory failure in the infected patients and require non-invasive respiratory support.
• 500 Beds and Above Hospitals are projected to capture over 51% of the global market by 2031. This is attributed to the growing burden of respiratory diseases.
• North America is the largest revenue-generating region for high flow oxygen therapy devices, with the U.S. accounting for nearly 96% of the regional market in 2031.
• South Asia is the second most lucrative market with India accounting for over 58% of the share in 2031.
• Japan holds the leading position in East Asia and is expected to account for over 42% of the market in 2031.

 “Increasing funding for R&D activities aimed launching novel products and solutions and healthcare recognition and recommendation of high-flow nasal cannula oxygen therapy will continue creating growth opportunities for manufacturers through the assessment period, ending in 2031,” says the FMI analyst

Who is winning?

Some of the leading manufacturers of high flow oxygen therapy devices are focusing on product approvals and launch strategies for global expansion objectives, thereby, enhancing their market presence. The leading key players are also focusing on innovation and launching new technologies for increasing the efficiency of products.

• In June 2020, Armstrong Medical introduced the second generation FD140i, an improved dual therapy flow driver with an easier transition from CPAP to HFOT.

• In 2019, TherOx Company received approval for SuperSaturated Oxygen Therapy system from the U.S. Food and Drug Administration (FDA) to be one of the effective therapies for cardiovascular diseases.

The key market players covered by FMI include Draegerwerk AG & Co. KGaA, Teleflex Medical GmBH, Philips Respironics, Vapotherm, Inc., ResMed, Vyaire Medical, Inc., Fisher & Paykel Corporation Ltd., Armstrong Medical, Flexicare Medical, Hamilton Medical Inc., Intersurgical Inc., Inspired Medical, WILAMed GmBH, Besmed Health Business Corp, Shenzhen Micomme Medical Technology Development Co., Ltd, Shenyang RMS Medical Tech Co. Ltd. and BMC Medical Co., Ltd.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13794

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global high flow oxygen therapy devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on high flow oxygen therapy devices segment based on the product (High Flow Nasal Cannulas, High Flow Oxygen Masks, Breathing Circuits, Heated Humidifiers and Accessories) Application (Pneumonia and Acute Respiratory Failure) End User (Less than 100 Beds Hospitals, 100-250 Beds Hospitals, 250-500 Beds Hospitals and 500 Beds and Above Hospitals) across seven major regions.

High Flow Oxygen Therapy Devices Market by Category Product: 

• High Flow Nasal Cannulas
• High Flow Oxygen Masks
• Breathing Circuits
• Heated Humidifiers
• Accessories

Application:

• Pneumonia
• Acute Respiratory Failure

End-User:

• Less than 100 Beds Hospitals
• 100-250 Beds Hospitals
• 250-500 Beds Hospitals
• 500 Beds and Above Hospitals

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13794

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The market for platelet rich plasma (PRP) Europe is expected to reach US$ 37.5 Mn in 2016, up from US$ 35.3 Mn in 2015. Adoption of platelet rich plasma in treating musculoskeletal injuries, including tennis elbow, Achilles tendinopathy, and plantar fasciitis, will continue to drive revenues. PRP therapy is also gaining traction in treating sports-related and geriatric injuries, owing to its minimally invasive procedure and quicker recovery time.

[250 Pages Report] As per Future Market Insights, the global infant incubators market was valued at around US$ 311.6 Mn in 2021 and is projected to exhibit a CAGR of 4.7% over the forecast period. It is set to reach an estimated valuation of US$ 518.2 Mn in 2032.

Attributes	Key Statistics
Global Infant Incubators Market Estimated Size (2022E)	US$ 327.9 Mn
Projected Market Valuation (2032F)	US$ 518.2 Mn
Value-based CAGR (2022-2032)	4.7%
Collective Value Share: Top 5 Countries (2022)	49.5%

The global infant incubators market is growing due to increased awareness regarding the health of newborns, rising prevalence of chronic infections, and surging cases of sudden unexpected deaths among infants in healthcare facilities. Additionally, the emergence of numerous epidemics and looming health risks they pose have further increased the demand for intensive care incubators across all healthcare facilities, thereby promoting market expansion.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15506

Besides, growing acceptance of infant incubators by various end users, including hospitals, as well as pediatric & neonatal intensive care units, would give the market a boost in the approaching years. The U.S. healthcare sector has been focusing on the importance of collaborative strategies by government bodies, which would boost the advancement in healthcare facilities. The National Network of Perinatal Quality Collaboratives (NNPQC), for instance, was established by the CDC and the March of Dimes to assist state-based PQCs in improving maternal and infant health outcomes statewide in a measurable manner.

These aforementioned factors will boost the market in the near future, as key companies are also concentrating on acquisitions and the development of novel products with improved efficacy in terms of environmental stability, infection protection, and durability.

Key Takeaways from Market Study

• By product, the intensive care incubators segment held approximately 3% of the global market share in 2021.
• Based on end user, the hospital segment generated a market share of around 7% in 2021.
• East Asia is considered to be the leading region in the market and it held a share of 3% in 2021.
• Europe accounted for a value share of 7% in 2021 owing to increasing number of preterm births in the region.
• China is projected to exhibit growth at a lucrative CAGR of 8% during the forecast period.

“Increased initiatives by government bodies to promote health safety solutions and growing prevalence of chronic illnesses among infants in healthcare facilities are estimated to propel the market,” says an analyst of Future Market Insights.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15506

Competitive Landscape

Although infant incubator producers are functioning at full capacity, demand has surpassed supply in recent years with the rising prevalence of chronic illnesses. The gap has had an impact on a wide range of end users, including healthcare practitioners and other industrial users.

The global infant incubators market is fragmented, and there are a wide range of regional, up-and-coming, as well as established businesses operating within it. Key stakeholders have started conducting promotional activities to introduce unique infant incubators with improved efficacy.

For instance,

• In April 2022, nearly two hundred portable incubators that were developed by utilizing technology co-invented by a Stanford MBA more than 10 years ago, were sent to Ukraine to offer life-saving warmth to babies born prematurely in hospitals and bomb shelters.
• Dräger’s new Ponta and Ambia ceiling supply systems, which went into effect on September 30, 2021, give hospitals a great deal of flexibility when designing workstations that support particular clinical requirements in the operating room, ICU, and NICU.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15506

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Infant incubator market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032. The global infant incubators market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on the product (intensive care incubator, and transport incubator), end users (hospitals, pediatric and neonatal intensive care units, others), across seven key regions of the world.

[263 Pages Report] Up from nearly half a million units sold in 2018, the global sales of electronic stethoscopes will observe a robust 7.2% growth in 2022. The electronic stethoscopes market is expected to create an incremental opportunity worth US$ 170.9 Mn between 2022 and 2029.

Key Manufacturers Continue to Strategize on New Product Launches in Electronic Stethoscopes Landscape

Almost 2/5^th of total adoption of electronic stethoscopes is registered at hospitals, the report underscores that there has been significant adoption by medical institutes in the recent past. In the next few years, medical institutes and ambulatory surgical centers are likely to create multiple opportunities for manufacturers of electronic stethoscopes.

More than half of the overall sales is accounted by amplifying electronic stethoscopes, as indicated by FMI’s analysis. While amplifying electronic stethoscopes provide results as accurate as digitizing electronic stethoscopes, the latter are associated with high maintenance owing to the presence of multiple electronic components. Amplifying electronic stethoscopes are thus expected to observe significant growth in revenue over the course of coming years.

Request Sample @– https://www.futuremarketinsights.com/reports/sample/rep-gb-9457

According to the report, the market attractiveness of amplifying stethoscopes is strongly backed by the increasing number of launches of new electronic stethoscopes by a number of small- and medium-sized companies. Electronic stethoscopes are rapidly replacing conventional variants across developed countries, predominantly owing to accelerated regulatory approvals.

• eKuore had launched the first wireless stethoscope for medical use.
• Eko had launched the first Android–connected digital stethoscope.
• In April 2018, Steth IO launched a digital smartphone-enabled stethoscope.

According to the report, approximately 60% of the electronic stethoscopes that are sold are enabled with Bluetooth technology and an integrated chest piece system. The former is however poised to witness a higher rate of adoption over the coming years.

North America Continues to Lead the Global Market for Electronic Stethoscopes

North America holds a considerable revenue share in the electronic stethoscopes market. With advancements in technology and the presence of a large number of healthcare facilities, electronic stethoscopes are being widely used in the region. Their ability to provide amplified sound output as well as reduce external sound makes it easy for medical professionals to detect sounds and provide proper treatment to patients.

FMI’s study has profiled some of the key companies operating in the global electronic stethoscopes market, including Eko Devices, eKuore, GlobalMed, 3M, Welch Allyn, Ambisea Technology Corp., Meditech Equipment Co., Ltd, HD Medical, Thinklabs, ADInstruments, and Cardionics Inc.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9457

Electronic Stethoscope Market by Category Product: 

• Amplifying Stethoscopes
• Digitizing Stethoscopes

End User:

• Hospitals
• Clinics
• Medical Institutes
• Ambulatory Surgical Centers
• Homecare Settings
• Medical Camps
• Catheterization Laboratories

Application:

• Integrated Chest-Piece System
• Wireless Transmission System (Bluetooth)
• Integrated Receiver Head-Piece System
• Other

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

This Automotive Suspension Control Arms market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Automotive Suspension Control Arms market.

Automotive suspension control arms are also known as A-arms. Automotive suspension control arms are hinged suspension link between the chassis and the suspension hub that carries the wheel. Automotive suspension control arms include both upper and lower arms. Automotive control arms support each wheel and provide a smooth ride to passenger/driver. Most of the vehicles have either one or two suspension control arms per wheel, on both rear and front suspension.

Generally, front-wheel drive vehicles use only lower suspension control arms, while SUVs, four-wheel drive, trucks and buses have both upper as well as lower suspension control arms. Presently, manufacturers of automotive suspension control arms are focusing on lightweight materials for reducing the weight of the component which increases the fuel efficiency of the vehicle.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-10342

Automotive Suspension Control Arms Market: Regional Overview

Automotive suspension control arms market is segmented into seven geographical regions including North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa. East Asia is expected to hold a significant share in the automotive suspension control arms market owing to increasing sales of compact passenger cars across the region. In China, the government reduces the tax rate on compact passenger cars which positively impact the sales of passenger cars. Moreover, increasing the adoption of electric vehicles in East Asia also positively affects the growth of the automotive suspension control arms market over the forecast period. East Asia is expected to grow with the relatively high growth rate over the assessment period due to the increasing spending power of the middle-class population and also rise in the standard of living. This factor is expected to fuel the growth of passenger car which affirmatively accelerates the growth of automotive suspension control arms market. North America & Europe are also estimated to account for the significant share in the global automotive control arms market owing to the presence of numerous automotive manufacturers across the regions. Further, Latin America, Middle East & Africa are also estimated to grow with the healthy CAGR over the assessment period.

Automotive Suspension Control Arms Market: Market Players

Examples of some of the market participants in the global Automotive Suspension Control Arms market identified across the value chain includes:-

• Magneti Marelli S.p.A.
• Bangkok Eagle Wings
• Nissan Kogyo Co., Ltd.
• Fawer Automotive Parts Limited Company
• BordWarner TorqTransfer Systems Beijing Co., Ltd
• Sumitomo Riko Co., Ltd.
• Donghee Slovakia s.r.o.
• TRW
• Hutchison S.A.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-10342

The Automotive Suspension Control Arms market report covers exhaustive analysis on:

• Automotive Suspension Control Arms market segments
• Automotive Suspension Control Arms market dynamics
• Automotive Suspension Control Arms market Size
• Automotive Suspension Control Arms market supply & demand
• Automotive Suspension Control Arms market current trends/issues/challenges
• Automotive Suspension Control Arms market Competition & Companies involved
• Automotive Suspension Control Arms market technology
• Automotive Suspension Control Arms market value chain

Regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC Countries, S. Africa, Northern Africa)